509 related articles for article (PubMed ID: 32120970)
21. Increased uterine androgen receptor protein abundance results in implantation and mitochondrial defects in pregnant rats with hyperandrogenism and insulin resistance.
Zhang Y; Hu M; Yang F; Zhang Y; Ma S; Zhang D; Wang X; Sferruzzi-Perri AN; Wu X; Brännström M; Shao LR; Billig H
J Mol Med (Berl); 2021 Oct; 99(10):1427-1446. PubMed ID: 34180022
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational cross-sectional study.
Bhide P; Kulkarni A; Dilgil M; Dhir P; Shah A; Gudi A; Homburg R
Gynecol Endocrinol; 2017 Oct; 33(10):801-806. PubMed ID: 28454499
[TBL] [Abstract][Full Text] [Related]
23. Altered aquaporin expression in women with polycystic ovary syndrome: hyperandrogenism in follicular fluid inhibits aquaporin-9 in granulosa cells through the phosphatidylinositol 3-kinase pathway.
Qu F; Wang FF; Lu XE; Dong MY; Sheng JZ; Lv PP; Ding GL; Shi BW; Zhang D; Huang HF
Hum Reprod; 2010 Jun; 25(6):1441-50. PubMed ID: 20378617
[TBL] [Abstract][Full Text] [Related]
24. MIF-mediated NF-κB signaling pathway regulates the pathogenesis of polycystic ovary syndrome in rats.
He Z; Wang Y; Zhuan L; Li Y; Tang ZO; Wu Z; Ma Y
Cytokine; 2021 Oct; 146():155632. PubMed ID: 34242901
[TBL] [Abstract][Full Text] [Related]
25. Role of Androgen Receptor for Reconsidering the "True" Polycystic Ovarian Morphology in PCOS.
Gao XY; Liu Y; Lv Y; Huang T; Lu G; Liu HB; Zhao SG
Sci Rep; 2020 Jun; 10(1):8993. PubMed ID: 32488141
[TBL] [Abstract][Full Text] [Related]
26. Chronic androgen excess in female mice does not impact luteinizing hormone pulse frequency or putative GABAergic inputs to GnRH neurons.
Coyle CS; Prescott M; Handelsman DJ; Walters KA; Campbell RE
J Neuroendocrinol; 2022 Apr; 34(4):e13110. PubMed ID: 35267218
[TBL] [Abstract][Full Text] [Related]
27. Androgen signaling in adipose tissue, but less likely skeletal muscle, mediates development of metabolic traits in a PCOS mouse model.
Xiong T; Rodriguez Paris V; Edwards MC; Hu Y; Cochran BJ; Rye KA; Ledger WL; Padmanabhan V; Handelsman DJ; Gilchrist RB; Walters KA
Am J Physiol Endocrinol Metab; 2022 Aug; 323(2):E145-E158. PubMed ID: 35658542
[TBL] [Abstract][Full Text] [Related]
28. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
[TBL] [Abstract][Full Text] [Related]
29. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
Fraissinet A; Robin G; Pigny P; Lefebvre T; Catteau-Jonard S; Dewailly D
Hum Reprod; 2017 Aug; 32(8):1716-1722. PubMed ID: 28854589
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic potentials of the natural plant flavonoid apigenin in polycystic ovary syndrome in rat model: via modulation of pro-inflammatory cytokines and antioxidant activity.
Darabi P; Khazali H; Mehrabani Natanzi M
Gynecol Endocrinol; 2020 Jul; 36(7):582-587. PubMed ID: 31888395
[TBL] [Abstract][Full Text] [Related]
31. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
Lie Fong S; Laven JSE; Duhamel A; Dewailly D
Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
[TBL] [Abstract][Full Text] [Related]
32. Androgen signaling pathways driving reproductive and metabolic phenotypes in a PCOS mouse model.
Aflatounian A; Edwards MC; Rodriguez Paris V; Bertoldo MJ; Desai R; Gilchrist RB; Ledger WL; Handelsman DJ; Walters KA
J Endocrinol; 2020 Jun; 245(3):381-395. PubMed ID: 32229702
[TBL] [Abstract][Full Text] [Related]
33. Glucocorticoid signaling and lipid metabolism disturbances in the liver of rats treated with 5α-dihydrotestosterone in an animal model of polycystic ovary syndrome.
Vojnović Milutinović D; Teofilović A; Veličković N; Brkljačić J; Jelača S; Djordjevic A; Macut D
Endocrine; 2021 May; 72(2):562-572. PubMed ID: 33449293
[TBL] [Abstract][Full Text] [Related]
34. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome.
Mannerås L; Cajander S; Holmäng A; Seleskovic Z; Lystig T; Lönn M; Stener-Victorin E
Endocrinology; 2007 Aug; 148(8):3781-91. PubMed ID: 17495003
[TBL] [Abstract][Full Text] [Related]
35. Dual targeting of TNF-α and free radical toxic stress as a promising strategy to manage experimental polycystic ovary.
Rezvanfar MA; Saeedi S; Mansoori P; Saadat S; Goosheh M; Shojaei Saadi HA; Baeeri M; Abdollahi M
Pharm Biol; 2016; 54(1):80-90. PubMed ID: 25955958
[TBL] [Abstract][Full Text] [Related]
36. Hypothalamic kiss1 mRNA and kisspeptin immunoreactivity are reduced in a rat model of polycystic ovary syndrome (PCOS).
Brown RE; Wilkinson DA; Imran SA; Caraty A; Wilkinson M
Brain Res; 2012 Jul; 1467():1-9. PubMed ID: 22668987
[TBL] [Abstract][Full Text] [Related]
37. Abnormal expression of HSP70 may contribute to PCOS pathology.
Wu G; Hu X; Ding J; Yang J
J Ovarian Res; 2019 Aug; 12(1):74. PubMed ID: 31399035
[TBL] [Abstract][Full Text] [Related]
38. Crocetin attenuates DHT-induced polycystic ovary syndrome in mice via revising kisspeptin neurons.
Hu Q; Jin J; Zhou H; Yu D; Qian W; Zhong Y; Zhang J; Tang C; Liu P; Zhou Y; Wang X; Sheng L
Biomed Pharmacother; 2018 Nov; 107():1363-1369. PubMed ID: 30257351
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of electroacupuncture in regulating the imbalance of AMH and FSH to improve follicle development and hyperandrogenism in PCOS rats.
Shi Y; Li L; Zhou J; Sun J; Chen L; Zhao J; Wu L; Cui Y; Wu L; Wu H
Biomed Pharmacother; 2019 May; 113():108687. PubMed ID: 30851546
[TBL] [Abstract][Full Text] [Related]
40. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
Alebić MŠ; Stojanović N; Duhamel A; Dewailly D
Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
